Discover

Soothing repair cream.

A soothing, repairing cream that repairs severe, chronic skin dryness and soothes atopy-prone skin.

DEXYANE MeD

Soothing repair cream

Medical device

  • Treats and limits the recurrence of eczema lesions.
  • Tested under dermatological control
  • Spaces out flare-ups, Anti-atopy
    • Soothing repair cream
    • Soothing repair cream
    • Soothing repair cream

      DEXYANE MeD

      Soothing repair cream

      Medical device Soothes atopy-prone skin - Restores - Soothes

      A soothing, repairing cream that repairs severe, chronic skin dryness and soothes atopy-prone skin.

      • Treats and limits the recurrence of eczema lesions.
      • Tested under dermatological control

      Usable by Babies - Children - Teenagers - Adults

      Age From 3 month(s)

      Suitable Body - face - hands

      Skin type Dry skin prone to atopy - Atopy-prone skin - Eczema

      Need Spaces out flare-ups - Anti-atopy

      Made in France

      • DEXYANE MeD Soothing repair cream repairs severe, chronic skin dryness and soothes atopy-prone skin*.
      • The skin is protected : its pleasant texture forms a semi-occlusive film on the surface.

      Benefit

      DEXYANE MeD Soothing repair cream can be used as a stand-alone treatment, in combination with, or as a follow-up to topical corticosteroids to treat and limit the recurrence of eczema lesions.

      Benefits

      • USE alone, in combination or in conjunction with topical corticosteroids.
      • PROTECTS the skin thanks to its pleasant texture which forms a semi-occlusive film on the surface.

      Texture benefit

      Pleasurable texture that forms a semi-occlusive surface film.

      Product scent

      Fragrance-free

      Packaging that does not contain recycled material
      Fully recyclable packaging

      2026-07-20

      *DEXYANE MeD Soothing repair cream is a class CE medical device. Carefully read the instruction leaflet provided. Do not use if pregnant or breastfeeding. Do not use on the mucous membranes or on the nappy area of children still in nappies. Avoid all direct contact with eyes. Ages 3 months and up. Manufacturer: Pierre Fabre Medical Devices.

      Application

      Frequency of use

      1 to 2 times a day

      Apply directly to inflammatory eczema lesions
      Use on its own or in combination with topical corticosteroids

      Precautions to use :
      • Do not use if you are allergic to any of the ingredients
      • If you experience an allergic reaction consult a doctor
      • Avoid contact with the eyes to prevent irritation
      • In case of contact with eyes, rinse immediately with clean water
      • If eye irritation persists seek medical attention
      • Do not use if pregnant or breastfeeding
      • Keep out of the reach of children
      • Do not use on the nappy area of children still in nappies or on mucous membranes
      • Do not exceed 30% of the body's surface
      • Close the tube tightly after use
      • If you experience any side effects as a result of using the product, seek medical advice

      Ingredients

      WATER (AQUA). GLYCERIN. CAPRYLIC/CAPRIC TRIGLYCERIDE. BUTYLENE GLYCOL. POLYSORBATE 60. GLYCERYL STEARATE. BUTYROSPERMUM PARKII (SHEA) BUTTER (BUTYROSPERMUM PARKII BUTTER). PROPYLENE GLYCOL. BEESWAX (CERA ALBA). PEG-100 STEARATE. 10-HYDROXYDECENOIC ACID. CAPRYLYL GLYCOL. CETYL ALCOHOL. CITRIC ACID. DISODIUM EDTA. GLYCYRRHETINIC ACID. GUANIDINE CARBONATE. POLYACRYLATE-13. POLYISOBUTENE. POLYSORBATE 20. SCLEROTIUM GUM. SORBITAN ISOSTEARATE

      The consumer is advised to systematically check the composition of the product before purchasing it.

      Results

      Relieves itching due to dryness and reduces the reactivity of atopy-prone skin.
      Significant improvement in the clinical signs after 3 days of applying DEXYANE MeD in combination with topical corticosteroids¹

        ¹Result of a comparative clinical study conducted on 54 adults aged 18-63 with moderate to severe atopy-prone skin on the arms or behind the knees. Product applied twice a day in combination with a topical corticosteroid, versus a corticosteroid alone, for 10 days, with clinical scoring from 0 to 18 after 3 days of application. Various clinical signs included, such as pruritus. PFDC study RV442A2013147-V1-04/03/2016; 91-92.
        Loading...